FdaApplication
NDA 215973
Identifiers
- fda_app_no: NDA215973
Properties
| Property | Value |
|---|---|
| applicant_name | GILEAD SCIENCES INC |
| application_type | NDA |
| approval_date | 2022-12-22 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SUNLENCA | LENACAPAVIR SODIUM | EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) | SOLUTION;SUBCUTANEOUS |
1 product